Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTI-CLOT peri-operative PK-guided factor VIII dosing in hemophilia A
NL-OMON47823Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Factor VIII in hemophilia A (3 arms), sponsored by Erasmus MC. Started May 2014; status: active, not recruiting.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON47823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47823.